Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule belonging to the phenol ether class of organic compounds. The structure features an isoxazole ring substituted with a pentyl chain linked via a phenoxy group to a dihydro-2-oxazolyl moiety. It is known as WIN 52035 and has been referenced in chemical and pharmacological databases as an experimental compound. Its primary reported biological target is the genome polyprotein; however, detailed mechanism of action data are limited. There are no approved therapeutic indications or clinical trial data available for this compound[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-(5-(4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-methylisoxazole.